June 2013
Volume 54, Issue 15
ARVO Annual Meeting Abstract  |   June 2013
The Pharmacokinetics and Aqueous Humor Penetration of Besifloxacin 0.6% and Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery
Author Affiliations & Notes
  • Ruth Evans
    Bucci Laser Vision Institute, Wilkes Barre, PA
  • Frank Bucci
    Bucci Laser Vision Institute, Wilkes Barre, PA
  • Footnotes
    Commercial Relationships Ruth Evans, None; Frank Bucci, Bausch & Lomb (F)
  • Footnotes
    Support None
Investigative Ophthalmology & Visual Science June 2013, Vol.54, 4290. doi:https://doi.org/
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Ruth Evans, Frank Bucci; The Pharmacokinetics and Aqueous Humor Penetration of Besifloxacin 0.6% and Moxifloxacin 0.5% in Patients Undergoing Cataract Surgery. Invest. Ophthalmol. Vis. Sci. 2013;54(15):4290. doi: https://doi.org/.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: To compare the aqueous penetration and pharmacokinetics of besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing phacoemulsification.

Methods: 120 patients participated in a randomized, single center, single-masked, active comparator, parallel group absorption study. Patients were randomized in a 1:1 ratio to receive either BESI (n=60) or MOXI (n=60) to 1 of 4 subgroups. Each pt. was instructed to take 1 drop QID for 3 days prior to their surgery. On the day of surgery, pts. were instructed to use their drops at 1 of 4 prearranged times. Aqueous samples were collected at 1,2,4, or 6 hours following their last drop.

Results: Aqueous concentrations were higher for MOXI when compared to BESI at all time periods. The mean aqueous penetration levels at ONE hour were BESI 49 / MOXI 489 ng/ml (p=0.001). The two hour levels were BESI 55 / MOXI 623 ng/ml (p=0.001). At FOUR hours the levels were BESI 74 / MOXI 331 ng/ml (p=0.01). At SIX hours following the last study drops the levels were BESI 47 / MOXI 329 ng/ml (p=0.005). The calculated mean AUC 1-6 was significantly greater for MOXI (2170.1 +/- 171.1) versus BESI (302.8 +/- 28.3) (p<0.0001). Penetration levels for MOXI peaked at 2 hours, and the 4 & 6 hour levels fell below that achieved at the initial 1 hour time period. Penetration levels for BESI peaked at the 4 hour time period, and the 6 hour level was essentially equal to the initial 1 hour time period.

Conclusions: MOXI 0.5% demonstrated significantly greater aqueous penetration vs. BESI 0.6% at all 4 time intervals studied. The AUC 1-6 for MOXI 0.5% was significantly greater than BESI 0.6%. Data for both penetration AND potency are required to evaluate the efficacy of a topical antibiotic. This study provides valuable information regarding the penetration to the aqueous of BESI vs. MOXI when used topically over time.

Keywords: 422 antibiotics/antifungals/antiparasitics • 716 small incision cataract surgery • 427 aqueous  

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.